Coronary Heart Disease
Conditions
Interventions
Intervention group and control group :Chinese patent medicine
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients with acute coronary syndrome after successful coronary artery interventional treatment for the first time; (2) Compliance with qi deficiency and blood stasis or blood stasis or sputum stasis mutual resistance; (3) To be aged from 30 to 75 years; (4) sign consent form voluntary.
Exclusion criteria
Exclusion criteria: (1) patients with left main coronary artery; (2) successful treatment of criminal vascular, but it still have a 70% or greater vascular lesions left; (3) TCM syndromes are complicated and it difficult to identify the specific syndrome; (4) Combination with severe valvular heart disease or severe liver and kidney incompetence, patients with primary disease such as hematopoietic system, nervous system and malignant tumor; (5) Heart function is IV level before intervention (heart function grade of NYHA or Killip); (6) Heart function is IV level after intervention (heart function grade of NYHA or Killip); (7) Patients with poor adherence; (8) Women during pregnancy and lactation; (9) Affect data collecting due to spirit or language; (10) Complicated with severe immune system or infectious disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality;cardiac death;nonfatal myocardial infarction;revascularization; | — |
Countries
China
Contacts
Public ContactShi Dazhuo
Outcome results
None listed